cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Theseus Pharmaceuticals Inc
9 watching
Current Price
$13.76
$0.72
(5.52%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
532.7M
52-Week High
52-Week High
15.21
52-Week Low
52-Week Low
4.01
Average Volume
Average Volume
0.07M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization532.7M
icon52-Week High15.21
icon52-Week Low4.01
iconAverage Volume0.07M
iconDividend Yield--
iconP/E Ratio--
What does the Theseus Pharmaceuticals Inc do?
Theseus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of targeted therapies for the treatment of cancer patients. Its lead product candidate is THE-630, a pan-KIT inhibitor for the treatment of gastrointestinal stromal tumors, which is in Phase I clinical trial. The company also develops fourth-generation EGFR inhibitor that is active against C797S, an EGFR mutation that causes resistance to first- or later-line osimertinib treatment in patients with non-small cell lung cancer. Its development programs address drug resistance mutations in key driver oncogenes, which are mutated genes that cause cancer. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.
Read More
How much money does Theseus Pharmaceuticals Inc make?
News & Events about Theseus Pharmaceuticals Inc.
Market News Video
1month ago
In trading on Thursday, shares of Theseus Pharmaceuticals Inc (THRX) crossed above their 200 day moving average of 7.32, changing hands as high as 8.30 per share. Theseus Pharmaceuticals Inc shares are currently trading up about 13% on the day...
PR Newswire
5 months ago
Theseus Pharmaceuticals to Participate at Upcoming September Investor Conferences Theseus Pharmaceuticals to Participate at Upcoming September Investor Conferences PR Newswire CAMBRIDGE, Mass., Sept. 6, 2022 CAMBRIDGE, Mass., Sept. 6, 2022 /PRNewswire/ -- Theseus Pharmaceuticals, Inc. (NASDAQ...
PR Newswire
6 months ago
Theseus Pharmaceuticals to Participate Virtually in Wedbush PacGrow Healthcare Conference Theseus Pharmaceuticals to Participate Virtually in Wedbush PacGrow Healthcare Conference PR Newswire CAMBRIDGE, Mass., Aug. 3, 2022 CAMBRIDGE, Mass., Aug. 3, 2022 /PRNewswire/ -- Theseus Pharmaceuticals, Inc...
PR Newswire
8 months ago
Theseus Pharmaceuticals Appoints Don Hayden to Board of Directors Theseus Pharmaceuticals Appoints Don Hayden to Board of Directors PR Newswire CAMBRIDGE, Mass., May 18, 2022 CAMBRIDGE, Mass., May 18, 2022 /PRNewswire/ -- Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) (Theseus or the Company), a...
PR Newswire
10 months ago
Theseus Pharmaceuticals Announces Preclinical Data Characterizing Next-Generation Epidermal Growth Factor Receptor (EGFR) Inhibitors at the 2022 American Association for Cancer Research (AACR) Annual Meeting Theseus Pharmaceuticals Announces Preclinical Data Characterizing Next-Generation Epidermal...
Frequently Asked Questions
Frequently Asked Questions
What is Theseus Pharmaceuticals Inc share price today?
plus_minus_icon
Can Indians buy Theseus Pharmaceuticals Inc shares?
plus_minus_icon
How can I buy Theseus Pharmaceuticals Inc shares from India?
plus_minus_icon
Can Fractional shares of Theseus Pharmaceuticals Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Theseus Pharmaceuticals Inc stocks?
plus_minus_icon
What is today’s traded volume of Theseus Pharmaceuticals Inc?
plus_minus_icon
What is today’s market capitalisation of Theseus Pharmaceuticals Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Theseus Pharmaceuticals Inc?
plus_minus_icon
What percentage is Theseus Pharmaceuticals Inc down from its 52-Week High?
plus_minus_icon
What percentage is Theseus Pharmaceuticals Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$13.76
$0.72
(5.52%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
EIGER BIOPHARMACEUTICALS INC
EIGER BIOPHARMACEUTICALS INC
$2.26
$0.00 (0.00 %)
SUMMIT THERAPEUTICS INC
SUMMIT THERAPEUTICS INC
$2.62
$-0.36 (-12.08 %)
Viking Therapeutics, Inc.
Viking Therapeutics, Inc.
$9.96
$0.40 (4.18 %)
Arbutus Biopharma Corporation
Arbutus Biopharma Corporation
$2.95
$0.05 (1.72 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
EIGER BIOPHARMACEUTICALS INC
EIGER BIOPHARMACEUTICALS INC
$2.26
$0.00 (0.00 %)
SUMMIT THERAPEUTICS INC
SUMMIT THERAPEUTICS INC
$2.62
$-0.36 (-12.08 %)
Viking Therapeutics, Inc.
Viking Therapeutics, Inc.
$9.96
$0.40 (4.18 %)
Arbutus Biopharma Corporation
Arbutus Biopharma Corporation
$2.95
$0.05 (1.72 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00